All In Biotech

Drug Trial Radar · NCT06924658

Metformin in Safety and Efficacy in Gouty Patients

the Impact of Metformin Use on Clinical Outcomes in Gouty Patients

Last checked: Nov 20, 2026Latest source record: Sep 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

70

Planned (sponsor's estimate)

Start

Apr 20, 2025

Primary completion

Nov 20, 2027

Study completion Nov 20, 2027

Sponsor

Lead sponsor
Mostafa BahaaAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Apr 11, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The most frequent crystal arthropathy is gout, which is also the most prevalent cause of inflammatory arthritis. Gouty Patients frequently have excruciating pain and swelling in their joints. Gout is linked to decreased health-related quality of life and functional disability. Gout and its associated diseases have been shown to have a significant impact on patients mortality and morbidities. Metformin, a biguanide, is used to manage diabetes by reducing insulin resistance and preventing comorbidities such as cerebrovascular and coronary artery disease, as well as providing renal protection to diabetic nephropathy patients

Conditions

  • Gout

Interventions

  • placeboOther

    Placebo will have the same look of metformin

  • MetforminDrug

    Metformin, a biguanide, is used to manage diabetes by reducing insulin resistance and preventing comorbidities such as cerebrovascular and coronary artery disease, as well as providing renal protection to diabetic nephropathy patients

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. - Clinical assessment of disease activityTime frame: 3 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Tanta Unuversity

    Tanta, Egypt · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.